Literature DB >> 21727084

Delivering diabetes care in the Philippines and Vietnam: policy and practice issues.

David Beran1, Michiyo Higuchi.   

Abstract

The aim of this study is the comparison of 2 studies looking at the barriers to access of diabetes care and medicines in the Philippines and Vietnam. These studies used the Rapid Assessment Protocol for Insulin Access. Diabetes care is provided in specialized facilities and appropriate referral systems are lacking. In Vietnam, no problems were reported with regard to diagnostic tools, whereas this was a concern in the public sector in the Philippines. Both countries had high prices for medicines in comparison to international standards. Availability of medicines was better in Vietnam than in the Philippines, especially with regard to insulin. This affected adherence as did a lack of patient education. As countries aim to provide health care to the majority of their populations through universal coverage, the challenge of diabetes cannot be neglected. Trying to achieve universal coverage in parallel to decentralization, national and local governments need adapted guidance for this.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21727084     DOI: 10.1177/1010539511412177

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  15 in total

Review 1.  The impact of health systems on diabetes care in low and lower middle income countries.

Authors:  David Beran
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  Health policy analysis for prevention and control of cardiovascular diseases and diabetes mellitus in Turkey.

Authors:  Bulent Kilic; Sibel Kalaca; Belgin Unal; Peter Phillimore; Shahaduz Zaman
Journal:  Int J Public Health       Date:  2014-05-11       Impact factor: 3.380

Review 3.  Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Authors:  David Beran; Margaret Ewen; Kasia Lipska; Irl B Hirsch; John S Yudkin
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

4.  Costing of diabetes mellitus type II in Cambodia.

Authors:  Steffen Flessa; Anika Zembok
Journal:  Health Econ Rev       Date:  2014-11-01

5.  Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.

Authors:  Yaser T Bazargani; Anthonius de Boer; Hubert G M Leufkens; Aukje K Mantel-Teeuwisse
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

Review 6.  Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.

Authors:  Wing Bun Chan; Jung Fu Chen; Su-Yen Goh; Thi Thanh Huyen Vu; Iris Thiele Isip-Tan; Sony Wibisono Mudjanarko; Shailendra Bajpai; Maria Aileen Mabunay; Pongamorn Bunnag
Journal:  Diabetes Metab Syndr Obes       Date:  2017-12-15       Impact factor: 3.168

7.  Estimating direct medical costs of type 2 diabetes mellitus in the Philippines: a protocol.

Authors:  Junice Yi Siu Ng; Ivan John Clement; Cecilia Jimeno; Rosa Allyn Sy; Roberto Mirasol; Pepito De La Pena; Araceli Panelo; Rima Tan; Melanie Santillan; Dana Bayani; Erik Wiebols
Journal:  BMJ Open       Date:  2020-07-28       Impact factor: 2.692

8.  Facilitators and Barriers to Chronic Disease Self-Management and Mobile Health Interventions for People Living With Diabetes and Hypertension in Cambodia: Qualitative Study.

Authors:  Lesley Steinman; Hen Heang; Maurits van Pelt; Mayuree Rao; James LoGerfo; Annette Fitzpatrick; Nicole Ide; Haixia Cui
Journal:  JMIR Mhealth Uhealth       Date:  2020-04-24       Impact factor: 4.773

9.  The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Authors:  Corrina Moucheraud; Cosima Lenz; Michaella Latkovic; Veronika J Wirtz
Journal:  BMJ Glob Health       Date:  2019-02-27

10.  Insulin prices, availability and affordability in 13 low-income and middle-income countries.

Authors:  Margaret Ewen; Huibert-Jan Joosse; David Beran; Richard Laing
Journal:  BMJ Glob Health       Date:  2019-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.